Evidence map›Paper›PMID 9717979›Full record

ArticleClinical and experimental immunology1998

Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

S P Moyes, R N Maini, R A Mageed

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S P MoyesThe Kennedy Institute of Rheumatology, London, UK.
R N Maini
R A Mageed

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of germinal centre-like structures and clonotypic expansion of lymphocytes in RA synovia may indicate a site-specific immune response to local antigens, rather than passively entrapped immune cells, that sustains synovial inflammation. In this study we compare the nature of immunoglobulin light chain variable region gene use in the synovium of RA patients with peripheral B cells to determine the nature of the synovial immune response. Using Vlambda and Vkappa gene fingerprinting, which relies on differences in CDR3 length, we demonstrate differences in the pattern of Vlambda and Vkappa use and clonotypic expansion of B cells between the synovium and peripheral blood of RA patients. Further, we show that some synovial rearrangements with long CDR3 are selectively expanded. These longer than usual CDR3 were generated by a number of mechanisms including N-additions. However, the observed differences were not uniform in different patients. These observations suggest that local synovial antigens drive significant numbers of T and B lymphocytes selected from an existing repertoire shaped by genetic and environmental factors. Further, the data argue against passive retention of most B cells in the synovium of RA patients.

Indexed as

Complementarity Determining RegionsGene Rearrangement, B-Lymphocyte, Light ChainAgedAged, 80 and overAmino Acid SequenceArthritis, RheumatoidBase SequenceBlood CirculationB-LymphocytesFemaleGenes, ImmunoglobulinHumansImmunoglobulin alpha-ChainsImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsComplementarity Determining RegionsImmunoglobulin alpha-ChainsImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Light ChainsImmunoglobulin Variable Region

Identifiers

PMID9717979
PMCPMC1905028
OpenAlexW2086272767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.